Trial
NCT04130399
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Indiana University
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Stereotactic Body Radiation Therapy (SBRT)
Why stopped
Study is being abandoned.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-17